PHAR

PHARMANETICS INC.
PHAR

Delisted

PHAR was delisted on the 12th of May, 2004.

Financial journalist opinion

Neutral
GlobeNewsWire
6 days ago
Pharming Group to present at the H.C. Wainwright 27th Annual Global Investment Conference
Leiden, the  Netherlands, September 3, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming management will participate in the H.C. Wainwright 27th Annual Global Investment Conference in New York on September 8-10, 2025.
Pharming Group to present at the H.C. Wainwright 27th Annual Global Investment Conference
Neutral
GlobeNewsWire
7 days ago
Pharming Group appoints Kenneth Lynard as Chief Financial Officer
Leiden, the Netherlands, September 2, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced the appointment of Kenneth Lynard as Chief Financial Officer (CFO), effective October 1, 2025.
Pharming Group appoints Kenneth Lynard as Chief Financial Officer
Positive
Zacks Investment Research
17 days ago
Wall Street Analysts See a 142.26% Upside in Pharming Group (PHAR): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 142.3% in Pharming Group (PHAR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts See a 142.26% Upside in Pharming Group (PHAR): Can the Stock Really Move This High?
Positive
Zacks Investment Research
1 month ago
Wall Street Analysts Think Pharming Group (PHAR) Could Surge 145.75%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 145.8% in Pharming Group (PHAR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Think Pharming Group (PHAR) Could Surge 145.75%: Read This Before Placing a Bet
Neutral
GlobeNewsWire
1 month ago
Pharming Group to participate in August investor conference
Leiden, the  Netherlands, August 4, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's management will participate in the following investor conference in the month of August:
Pharming Group to participate in August investor conference
Neutral
Seeking Alpha
1 month ago
Pharming Group N.V. (PHAR) Q2 2025 Earnings Call Transcript
Pharming Group N.V. (NASDAQ:PHAR ) Q2 2025 Earnings Conference Call July 31, 2025 7:30 AM ET Executives Anurag Relan – Chief Medical Officer Fabrice Chouraqui – CEO & Executive Director Stephen Toor – Chief Commercial Officer & GM Americas Analysts Benjamin Jackson - Jefferies Jeffrey Michael Jones - Oppenheimer & Co. Inc., Research Division Simon Scholes - First Berlin Equity Research GmbH Sushila Hernandez - Kempen & Co Fabrice Chouraqui Good morning or good afternoon, everyone, and welcome to our Q2 2025 earnings call.
Pharming Group N.V. (PHAR) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
New Strong Buy Stocks for August 1st
ROKU, PHAR, ASC, META and ARI have been added to the Zacks Rank #1 (Strong Buy) List on August 1, 2025.
New Strong Buy Stocks for August 1st
Neutral
GlobeNewsWire
1 month ago
Pharming Group reports second quarter and first half 2025 financial results and provides business update
Leiden, the Netherlands, July 31, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) presents its preliminary (unaudited) financial report for the second quarter and first half year ended June 30, 2025.
Pharming Group reports second quarter and first half 2025 financial results and provides business update
Positive
Zacks Investment Research
1 month ago
Best Momentum Stocks to Buy for July 25th
RVLV, PHAR and AMZN made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 25, 2025.
Best Momentum Stocks to Buy for July 25th
Positive
Zacks Investment Research
1 month ago
New Strong Buy Stocks for July 25th
PHIN, MBWM, THC, RVLV and PHAR have been added to the Zacks Rank #1 (Strong Buy) List on July 25, 2025.
New Strong Buy Stocks for July 25th
Charts implemented using Lightweight Charts™